Your browser doesn't support javascript.
loading
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.
Boland, Brigid S; Goodwin, Benjamin; Zhang, Zeli; Bloom, Nathaniel; Kato, Yu; Neill, Jennifer; Le, Helen; Tysl, Tiffani; Collins, Angelina E; Dulai, Parambir S; Singh, Siddharth; Nguyen, Nghia H; Grifoni, Alba; Sette, Alessandro; Weiskopf, Daniela; Chang, John T; Dan, Jennifer M.
Afiliación
  • Boland BS; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Goodwin B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Zhang Z; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Bloom N; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Kato Y; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Neill J; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Le H; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Tysl T; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Collins AE; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Dulai PS; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Singh S; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Nguyen NH; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
  • Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Weiskopf D; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA.
  • Chang JT; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Dan JM; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
Clin Transl Gastroenterol ; 13(4): e00484, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35347100
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Enfermedades Inflamatorias del Intestino / COVID-19 Límite: Humans Idioma: En Revista: Clin Transl Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Enfermedades Inflamatorias del Intestino / COVID-19 Límite: Humans Idioma: En Revista: Clin Transl Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos